Cancer Cytopathology

Cancer Cytopathology   

Principal Editor: Celeste N. Powers, MD, PhD  

Cancer Cytopathology is a peer-reviewed publication of the American Cancer Society integrating scientific information from cytopathology. The objective of Cancer Cytopathology is to provide a forum for the exchange of information among cytopathologists and related oncologic disciplines concerned with the etiology and course of human cancer and its diagnosis and prevention. 

Cancer Cytopathology is happy to consider Original Articles and Review Articles that focus on:

  • Gynecologic Cytopathology
  • Non-Gynecologic Cytopathology
  • Fine-Needle Aspiration
  • Immunocytochemistry
  • Molecular Diagnostics and Cytogenetics
  • Analytical and Quantitative Cytopathology

Top Reasons Why You Should Submit Your Paper to Cancer Cytopathology:

  • Quick Decisions – average time to first decision is less than 4 weeks
  • Impact Factor – With an Impact Factor of 2.471 (2008, Thomson ISI), Cancer Cytopathology has the highest score among cytopathology journals
  • Global Reach – access to Cancer Cytopathology in the United States and around the world extends to over 20 million people
  • EarlyView® — Immediately following final approval, your article is posted online, often 8-10 weeks before the print version
  • No Author Charges — Cancer Cytopathology does not impose any author fees for submission, extra pages, or color figures
  • No Rewriting — Cancer Cytopathology reviewers and editors provide valuable feedback to authors; however, they do not rewrite manuscripts
  • All Content Online – all articles over 12 months old are freely available
  • Visibility – maximum visibility with your peers as the official journal of the American Society of Cytopathology

Access the latest articles at: Cancer Cytopathology

Publisher: Wiley-Blackwell, on behalf of the American Cancer Society